Lactic Acid: A Novel Signaling Molecule in Early Pregnancy?

Aerobic glycolysis is a recognized feature shared by tumors, leading to the accumulation of lactic acid in their local microenvironments. Like the tumors, the blastocysts, placenta, trophoblasts and decidual immune cells can also produce a large amount of lactic acid through aerobic glycolysis durin...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 11; p. 279
Main Authors Ma, Li-Na, Huang, Xiao-Bo, Muyayalo, Kahindo P, Mor, Gil, Liao, Ai-Hua
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 27.02.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aerobic glycolysis is a recognized feature shared by tumors, leading to the accumulation of lactic acid in their local microenvironments. Like the tumors, the blastocysts, placenta, trophoblasts and decidual immune cells can also produce a large amount of lactic acid through aerobic glycolysis during the early pregnancy. Moreover, the placenta expresses the transporters of the lactic acid. While several studies have described the role of lactic acid in the tumor microenvironment, especially lactic acid's modulation of immune cells, the role of lactic acid produced during pregnancy is still unclear. In this paper, we reviewed the scientific evidence detailing the effects of lactic acid in the tumor microenvironment. Based on the influence of the lactic acid on immune cells and tumors, we proposed that lactic acid released in the unique uterine environment could have similar effects on the trophoblast cells and immune cells during the early pregnancy.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Reviewed by: Gabor Laszlo Kovacs, University of Pécs, Hungary; Nandor Gabor Than, Research Centre for Natural Sciences, Hungarian Academy of Sciences (MTA), Hungary
This article was submitted to Immunological Tolerance and Regulation, a section of the journal Frontiers in Immunology
Edited by: Julia Szekeres-Bartho, University of Pécs, Hungary
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2020.00279